CD68 is a heavily glycosylated transmembrane protein found predominantly on the surface and inside the lysosomes of monocytes, macrophages, and related cells. For decades it has served as the go-to histological stain for identifying macrophages in tissue samples, but its actual biological roles turn out to be more varied and more nuanced than a simple identity tag. CD68 participates in binding oxidized cholesterol, recognizing dying cells, and facilitating the internal digestive machinery that macrophages rely on to clear debris and pathogens. Because macrophages themselves are not a single cell type but a diverse family with strikingly different behaviors depending on context, CD68’s expression and functional significance shift across tissues, disease states, and macrophage subtypes in ways that matter for both research and clinical diagnosis.
What CD68 Actually Is
CD68, sometimes called macrosialin in mice, is a type I transmembrane protein of about 354 amino acids. Its extracellular portion is split into two distinct zones by a proline-rich hinge: a mucin-like domain near the tip, packed with sugar attachment sites, and a domain closer to the membrane that resembles a family of lysosomal proteins known as the LAMP group. The mucin-like region is roughly half serine and threonine residues, which are heavily decorated with sugar chains, giving the protein a thick carbohydrate coat.1PubMed. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins This sugar armor likely protects the protein from being degraded in the harsh acidic environment of lysosomes, which is exactly where most CD68 resides inside the cell.
Although CD68 sits on the outer cell membrane as well, the bulk of it is found on the membranes of late endosomes and lysosomes, the compartments where macrophages digest engulfed material.2Journal of Biological Chemistry. Progranulin-derived granulin E and lysosome membrane protein CD68 interact to reciprocally regulate their protein homeostasis This internal localization is central to understanding what CD68 does: it is less about signaling the outside world and more about equipping the cell’s internal recycling and destruction machinery.
Known Biological Functions
For a protein used so widely in laboratory staining, CD68’s function was described for years as “unknown.” Research has since pinned down several roles, though the full picture is still incomplete. CD68 has been shown to bind oxidized low-density lipoprotein (oxLDL), the modified cholesterol particles that accumulate inside artery walls during atherosclerosis. It also binds phosphatidylserine, a lipid that flips to the outer surface of cells undergoing programmed death, flagging them for cleanup. And it acts as a receptor for malaria sporozoites during liver infection, giving the parasite an entry route into host cells.3Laboratory Investigation. CD68/macrosialin: not just a histochemical marker
The oxLDL-binding role has drawn particular attention in cardiovascular research. Macrophages that gorge on cholesterol-rich particles through scavenger receptors like CD68 transform into foam cells, the lipid-laden cells that form the core of atherosclerotic plaques. Blocking this uptake with a soluble form of CD68 has been explored experimentally as a way to slow plaque formation.4PubMed. Inhibition of foam cell formation using a soluble CD68-Fc fusion protein The connection makes intuitive sense: a lysosomal protein that can grab modified cholesterol is perfectly positioned to contribute to the runaway lipid accumulation that defines foam cells.
CD68 Across Macrophage Subtypes
Macrophages are often loosely grouped into “M1” (pro-inflammatory, geared toward killing pathogens) and “M2” (anti-inflammatory, geared toward tissue repair) subtypes, though the reality is a continuous spectrum rather than two neat bins. A common question in immunology is whether CD68 marks one subtype more than the other. The short answer is that it does not. CD68 messenger RNA is well expressed across all macrophage subtypes, and its protein level climbs sharply when monocytes mature into macrophages regardless of whether they adopt an M1 or M2 profile.5PubMed Central. Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers This makes CD68 a “pan-macrophage” marker rather than a subtype-specific one.
In practice, researchers who want to distinguish M1 from M2 macrophages in tissue combine CD68 with a second stain. For M1 identification, CD68 is commonly paired with markers like iNOS (inducible nitric oxide synthase) or pSTAT1. For M2, the partner is often CD163 or cMAF. In conditions driven by a strong inflammatory (Th1-type) immune response, tissue sections show more CD68-positive cells co-staining with pSTAT1, while in conditions skewed toward a repair-oriented (Th2-type) response, CD68-positive cells co-staining with cMAF predominate.6PLOS ONE. Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages CD68 on its own, then, tells you macrophages are present; it does not tell you what they are doing.
Microglia and the Brain
Microglia are the brain’s resident macrophages, and they express CD68 abundantly. In this context, CD68 staining is widely used as a readout of phagocytic activity rather than mere presence. Resting microglia show low-level CD68, but when they become activated and begin engulfing debris or damaged neurons, CD68 levels climb because the lysosomal compartment expands to handle the workload.
This relationship has been studied extensively in Alzheimer’s disease. A systematic review of post-mortem brain studies found that 17 out of 21 comparisons identified higher CD68 expression in Alzheimer’s brains relative to controls in at least one brain region.7Molecular Psychiatry. Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review The association between CD68 and cognitive decline, tau tangles, and neuritic plaques is strong. What remains unresolved is whether microglia expressing high CD68 are causing harm by actively destroying functioning neurons and synapses or simply cleaning up debris left by neurons that were already dying.8PubMed Central. Microglial immunophenotype in dementia with Alzheimer’s pathology That distinction matters enormously for therapy: if phagocytic microglia are contributors to neurodegeneration, suppressing them could help; if they are responders, suppressing them might make things worse.
Tumor-Associated Macrophages and Cancer Prognosis
Solid tumors are infiltrated by macrophages that the tumor microenvironment often co-opts to support growth and suppress immune attack. These tumor-associated macrophages (TAMs) are routinely quantified using CD68 staining. In many cancer types, a high density of CD68-positive TAMs has been linked to worse outcomes. In esophageal squamous cell carcinoma, for instance, higher CD68-positive TAM counts in the tumor correlated with lymph node spread, more advanced clinical stage, and shorter survival.9PubMed Central. High infiltration of CD68-tumor associated macrophages, predict poor prognosis in Kazakh esophageal cancer patients
But the picture is not uniform across cancers. In head and neck squamous cell carcinoma, a meta-analysis found that low CD68-positive TAM counts correlated with better overall survival, but the association did not reach significance for disease-free survival or recurrence.10Oral Oncology. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis An earlier meta-analysis of similar cancers actually found no significant association at all between CD68-positive TAMs and overall survival.11Oral Oncology. Prognostic significance of CD68+ and CD163+ tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis This inconsistency likely reflects the fact that CD68 labels all macrophages without distinguishing the pro-tumor M2-like cells from the anti-tumor M1-like ones. A tumor loaded with CD68-positive cells could have a favorable mix or a harmful one, and the stain alone cannot tell you which.
This is exactly why CD163, a marker more specific to M2-like macrophages, has emerged as a stronger prognostic tool. In classical Hodgkin lymphoma, pathologists comparing CD163 and CD68 staining found that CD163 produced cleaner results with less background noise and less staining of the tumor cells themselves.12PubMed Central. CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma In another study of the same disease, CD163 staining predicted overall survival with statistical significance while CD68 staining did not, and pathologists agreed more consistently on CD163 scoring.13PubMed. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma The takeaway for clinicians is that CD68 remains useful for confirming macrophage infiltration, but subtype-specific markers often carry more prognostic weight.
CD68 in Infectious Disease and Granulomas
When the immune system cannot fully eliminate an intracellular pathogen, macrophages wall it off in a structure called a granuloma. CD68 staining is a standard way to identify the macrophage component of these structures. In a humanized mouse model of mycobacterial infection, granulomas in the liver and lungs contained a core of CD68-positive macrophages and giant cells surrounded by a ring of T cells and a fibrotic capsule.14PubMed Central. CD4+ cell-dependent granuloma formation in humanized mice infected with mycobacteria This architecture mirrors what is seen in human tuberculosis.
In cattle naturally infected with bovine tuberculosis, CD68-positive macrophages were most abundant in early-stage granulomas, where they appeared alongside iNOS and HLA-DR markers, suggesting a pro-inflammatory environment aimed at controlling the infection. As granulomas matured, the pattern shifted.15PubMed Central. Monitoring the immune response of macrophages in tuberculous granuloma through the expression of CD68, iNOS and HLA-DR in naturally infected beef cattle CD68 staining here tracks the intensity and timing of the macrophage response to infection, providing a window into whether the immune system is still actively fighting or has shifted into a more contained, chronic state.
Rheumatoid Arthritis and Treatment Monitoring
One of the more practical applications of CD68 staining lies in rheumatoid arthritis. The inflamed joint lining in rheumatoid arthritis is heavily infiltrated by macrophages, and the number of CD68-positive macrophages in the deeper sublining layer of the synovial tissue turns out to be a sensitive readout of how well treatment is working. In a study of patients classified as good, moderate, or non-responders based on clinical disease activity scores, the change in sublining macrophage counts tracked closely with the degree of clinical improvement. Good responders showed the largest drop, moderate responders a smaller drop, and non-responders barely any change, with a strong correlation between macrophage reduction and disease activity improvement.16PubMed. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis
Animal models reinforce the point. In arthritic rats treated with celastrol, a plant-derived compound with anti-inflammatory properties, the number of CD68-positive synovial macrophages dropped significantly compared to untreated arthritic controls.17PubMed Central. Decrease of CD68 Synovial Macrophages in Celastrol Treated Arthritic Rats The consistency of this pattern across species and treatments has led some researchers to propose sublining CD68-positive macrophage counts as a standard biomarker for early-phase clinical trials in rheumatoid arthritis, where you need a tissue-level measure of whether a drug is actually dampening inflammation at the site of disease.
The Specificity Problem
Here is where the conventional wisdom about CD68 gets into trouble. For years, CD68 was treated as essentially synonymous with macrophages. If a cell stained positive for CD68, it was called a macrophage. But research has shown that fibroblasts, endothelial cells, some lymphocytes, and several tumor cell lines also express CD68 protein and mRNA. In one study, primary fibroblasts from normal skin, normal breast tissue, breast tumor tissue, and osteoarthritis synovium expressed CD68 at levels comparable to macrophages.18PubMed. The “classical” macrophage marker CD68 is strongly expressed in primary human fibroblasts A separate group confirmed the same pattern, finding significant CD68 staining in fibroblasts and endothelial cells and concluding that CD68 is better understood as a lysosomal protein enriched in macrophages rather than a selective macrophage marker.19PubMed. Expression of CD68 in non-myeloid cell types
This matters in practice because tissues rich in fibroblasts, like the stroma surrounding tumors or the lining of joints, are exactly the places where researchers are trying to count macrophages. If the stain also lights up the fibroblasts next door, macrophage counts can be inflated, potentially skewing prognostic assessments or research conclusions.
Antibody Clones and Why They Behave Differently
Not all anti-CD68 antibodies are created equal. The three most commonly used clones in clinical and research pathology are KP1, EBM11, and PG-M1, and they recognize different parts of the CD68 protein, which gives them different specificity profiles. KP1 and EBM11 react broadly with both macrophages and other myeloid cells, and when tested against fibroblasts using intracellular staining, nearly all fibroblasts stained positive for both clones.20PubMed Central. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry PG-M1, by contrast, targets a fixative-resistant epitope on a form of CD68 that is restricted to macrophages, sparing most myeloid precursors and, importantly, fibroblasts.21PubMed Central. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule
The practical lesson is that a study reporting “CD68-positive macrophage counts” could be measuring something quite different depending on which antibody clone was used. KP1 is the most widely deployed and also the least specific. When comparing studies or interpreting pathology reports, knowing the clone matters. The growing shift toward PG-M1 or toward pairing CD68 with additional markers reflects the field’s acknowledgment that the classic KP1-based approach, while convenient, has real blind spots.
CD68 in Bone Remodeling
Osteoclasts, the cells responsible for breaking down bone, are derived from the same monocyte-macrophage lineage that produces tissue macrophages, and they express CD68 heavily. In mature osteoclasts, CD68 concentrates around the cell’s periphery and along the surface facing the bone, forming a dome-like distribution visible under high-resolution imaging. When researchers genetically deleted CD68 in mice, the osteoclasts that formed were abnormal: they resorbed significantly less bone, accumulated unusual intracellular vesicle-like structures, took on distorted shapes after staining, and were more easily detached from surfaces.22PLOS ONE. Genetic Ablation of CD68 Results in Mice with Increased Bone and Dysfunctional Osteoclasts These mice ended up with increased bone mass, the predictable result of having osteoclasts that cannot do their job properly.
This finding is one of the clearest demonstrations that CD68 is not just a passive bystander in the cells that express it. In osteoclasts, it appears to play a structural or trafficking role that the cell needs for normal function, particularly for maintaining the membrane architecture required for bone resorption.
CD68 Beyond Mammals
CD68 is not unique to humans or even to mammals. The murine version, macrosialin, shares about 72% amino acid identity with human CD68, with particularly strong conservation in the LAMP-like domain and proline hinge. The gene has also been identified in fish. In blunt snout bream, a freshwater cyprinid, the CD68 protein has high homology with versions found in other fish species, and analysis of evolutionary selection pressure shows that teleost CD68 has been under positive selection, meaning the protein has been actively shaped by natural selection rather than simply drifting.23PubMed Central. Molecular Characterization, Expression, Evolutionary Selection, and Biological Activity Analysis of CD68 Gene from Megalobrama amblycephala The LAMP protein family to which CD68 belongs traces back even further; phylogenetic analyses of LAMP genes suggest the vertebrate versions arose after the divergence of sea squirts and vertebrates roughly 500 million years ago, with additional gene duplications occurring in the teleost fish lineage.24Molecular Biology and Evolution. Chaperone-Mediated Autophagy in the Light of Evolution: Insight from Fish
The fact that CD68 has been conserved and actively selected across such a wide range of vertebrates reinforces the idea that it performs functions important enough for survival to maintain. A purely decorative identity badge would not be under positive selection pressure in fish separated from humans by hundreds of millions of years of evolution.
Fetal Origins of Tissue Macrophages
Many of the macrophages that reside permanently in adult organs do not come from bone marrow. Instead, they originate during embryonic development from progenitor cells in the yolk sac and seed various tissues before birth. In the developing heart, these early macrophage precursors express both CD68 and another marker called LYVE1, and they require the epicardium, the thin outer layer of the heart, to successfully colonize the cardiac tissue. Without a properly formed epicardium, the yolk-sac macrophages fail to take up residence, leaving the adult heart without its normal complement of resident immune cells. This developmental pathway underscores that CD68 expression begins very early in the macrophage lineage, well before the cells take on the specialized identities they will hold in adult tissues.
Soluble CD163 as a Complementary Circulating Marker
While CD68 is primarily studied in tissue sections, clinicians interested in macrophage activity in living patients increasingly look at soluble CD163 (sCD163), which is shed from the surface of activated macrophages into the bloodstream. In patients with complex regional pain syndrome, a chronic pain condition, sCD163 levels were significantly higher than in healthy controls, suggesting macrophage activation as part of the disease process.25PubMed Central. Elevated Serum Soluble CD163 Indicates Macrophage Activation: A Potential Biomarker for Inflammation in Complex Regional Pain Syndrome? Soluble CD163 offers something that tissue-based CD68 staining cannot: a blood test that can be repeated over time without biopsies, making it useful for tracking inflammatory diseases longitudinally. The two markers are complementary rather than competing. CD68 tells you where macrophages are in tissue and roughly how active their lysosomal machinery is; sCD163 tells you how much macrophage activation is happening systemically.